This protocol addresses women with congenital hypothyroidism (CH) who are planning pregnancy or are currently pregnant. In this population, thyroid hormone requirements shift substantially, and management of congenital iodine-deficiency must be adapted accordingly.
Women in this situation should receive counselling about the anticipated change in LT4 requirements during gestation, ideally before conception.
Management centres on optimising levothyroxine (LT4) therapy, with a dose adjustment expected during pregnancy for most women, combined with attention to adequate daily iodine intake. The complete structured regimen — including the specific adjustments, monitoring schedule, and decision algorithm — is available via the protocol link below.
The primary goal in LT4-treated women is maintaining serum TSH below 2.5 mU/L throughout gestation. In pregnant women with central CH, free T4 (fT4) is targeted above the mean/median value of the trimester-specific reference interval.
DOI: 10.1089/thy.2020.0333
View source ↗